BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29439188)

  • 1. Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study.
    Schommers P; Gillor D; Hentrich M; Wyen C; Wolf T; Oette M; Zoufaly A; Wasmuth JC; Bogner JR; Müller M; Esser S; Schleicher A; Jensen B; Stoehr A; Behrens G; Schultze A; Siehl J; Thoden J; Taylor N; Hoffmann C
    Haematologica; 2018 May; 103(5):857-864. PubMed ID: 29439188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphomas associated with HIV infection in patients at the Hospital San Borja Arriarán /Fundación Arriarán 2001-2008, Santiago, Chile].
    Pizarro A; García H; Riquelme A; Carmona J; Cortés C
    Rev Chilena Infectol; 2013 Feb; 30(1):23-30. PubMed ID: 23450406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
    Gisselbrecht C; Oksenhendler E; Tirelli U; Lepage E; Gabarre J; Farcet JP; Gastaldi R; Coiffier B; Thyss A; Raphael M
    Am J Med; 1993 Aug; 95(2):188-96. PubMed ID: 7689296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas.
    Hagemeister FB; Khetan R; Allen P; McLaughlin P; Rodriguez MA; Swan F; Romaguera JE; Cabanillas F
    Ann Oncol; 1994; 5 Suppl 2():41-6. PubMed ID: 8204519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant gastrointestinal lymphomas in patients with AIDS.
    Heise W; Arastéh K; Mostertz P; Skörde J; Schmidt W; Obst C; Koeppen M; Weiss R; Grosse G; Niedobitek F; L'Age M
    Digestion; 1997; 58(3):218-24. PubMed ID: 9243116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
    Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
    Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors.
    Miralles P; Berenguer J; Ribera JM; Rubio R; Mahillo B; Téllez MJ; Lacruz J; Valencia E; Santos J; Rodríguez-Arrondo F; Pintado V;
    J Acquir Immune Defic Syndr; 2007 Feb; 44(2):167-73. PubMed ID: 17117144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent Prognosis.
    Kriegsmann K; Klee JS; Hensel M; Buss EC; Kriegsmann M; Cremer M; Ho AD; Egerer G; Wuchter P; Witzens-Harig M
    Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):e581-e587. PubMed ID: 31377211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
    Boué F; Gabarre J; Gisselbrecht C; Reynes J; Cheret A; Bonnet F; Billaud E; Raphael M; Lancar R; Costagliola D
    J Clin Oncol; 2006 Sep; 24(25):4123-8. PubMed ID: 16896005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
    Hoffmann C; Wolf E; Wyen C; Fätkenheuer G; Van Lunzen J; Stellbrink HJ; Stoehr A; Plettenberg A; Jaeger H; Noppeney R; Hentrich M; Goekbuget N; Hoelzer D; Horst HA
    Leuk Lymphoma; 2006 Sep; 47(9):1872-80. PubMed ID: 17065000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphomas and HIV infection in a reference hospital of Santiago, Chile: 1990-2002: report of 14 cases and review].
    Osorio S G; Montenegro U C
    Rev Chilena Infectol; 2007 Apr; 24(2):117-24. PubMed ID: 17453069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin lymphoma among patients infected with HIV in post-HAART era.
    Tanaka PY; Pessoa VP; Pracchia LF; Buccheri V; Chamone DA; Calore EE
    Clin Lymphoma Myeloma; 2007 Mar; 7(5):364-8. PubMed ID: 17562247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
    Oksenhendler E; Gerard L; Dubreuil ML; Levy Y; Matheron S; Cazals-Hatem D; Chevret S; Clauvel JP
    Leuk Lymphoma; 2000 Sep; 39(1-2):87-95. PubMed ID: 10975387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with survival in patients with lymphoma and HIV.
    Vargas JC; Marques MO; Pereira J; Braga WMT; Hamerschlak N; Tabacof J; Ferreira PRA; Colleoni GWB; Baiocchi OCG
    AIDS; 2023 Jul; 37(8):1217-1226. PubMed ID: 36939075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
    Hentrich M; Berger M; Wyen C; Siehl J; Rockstroh JK; Müller M; Fätkenheuer G; Seidel E; Nickelsen M; Wolf T; Rieke A; Schürmann D; Schmidmaier R; Planker M; Alt J; Mosthaf F; Engert A; Arasteh K; Hoffmann C
    J Clin Oncol; 2012 Nov; 30(33):4117-23. PubMed ID: 23045592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.
    Olszewski AJ; Fallah J; Castillo JJ
    Cancer; 2016 Sep; 122(17):2689-97. PubMed ID: 27337679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage chemotherapy according to the ASHAP protocol: a single-center study of 24 patients with relapsed or refractory aggressive non-Hodgkin's lymphomas.
    Nückel H; Dürig J; Dührsen U
    Ann Hematol; 2003 Aug; 82(8):481-486. PubMed ID: 12910375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
    Schlembach PJ; Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1107-10. PubMed ID: 11072169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.